BR102016013818A8 - promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo - Google Patents

promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo

Info

Publication number
BR102016013818A8
BR102016013818A8 BR102016013818A BR102016013818A BR102016013818A8 BR 102016013818 A8 BR102016013818 A8 BR 102016013818A8 BR 102016013818 A BR102016013818 A BR 102016013818A BR 102016013818 A BR102016013818 A BR 102016013818A BR 102016013818 A8 BR102016013818 A8 BR 102016013818A8
Authority
BR
Brazil
Prior art keywords
nucleotide sequence
inducible promoter
drug
sequence
identity
Prior art date
Application number
BR102016013818A
Other languages
English (en)
Inventor
Nishimura Satoru
Tsuzuki Shoko
Original Assignee
Toyota Motor Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyota Motor Co Ltd filed Critical Toyota Motor Co Ltd
Publication of BR102016013818A8 publication Critical patent/BR102016013818A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8205—Agrobacterium mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo. a presente invenção refere-se a um promotor induzível por medicamento que pode ser utilizado para plantas de cana de açúcar e plantas com estas relacionadas. tal promotor induzível por medicamento compreende um polinucleotídeo que compreende uma primeira sequência de nucleotídeo que possui 90% ou mais de identidade com a sequência de nucleotídeo como apresentada na seq id no: 1, uma segunda sequência de nucleotídeo que possui 90% ou mais de identidade com a sequência de nucleotídeo como apresentada na seq id no: 2, uma terceira sequência de nucleotídeo que possui 90% ou mais de identidade com a sequência de nucleotídeo como apresentada na seq id no: 3, uma quarta sequência de nucleotídeo que possui 90% ou mais de identidade com a sequência de nucleotídeo como apresentada na seq id no: 4 e uma quinta sequência de nucleotídeo que possui 90% ou mais de identidade com a sequência de nucleotídeo como apresentada na seq id no: 5, em uma tal ordem a partir do lado terminal 3' para o lado terminal 5'.
BR102016013818A 2015-06-25 2016-06-15 promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo BR102016013818A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015128038A JP6274161B2 (ja) 2015-06-25 2015-06-25 薬剤誘導性プロモーター及びこれを用いた遺伝子発現誘導方法

Publications (1)

Publication Number Publication Date
BR102016013818A8 true BR102016013818A8 (pt) 2018-02-27

Family

ID=57651373

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102016013818A BR102016013818A8 (pt) 2015-06-25 2016-06-15 promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo

Country Status (5)

Country Link
US (1) US10968457B2 (pt)
JP (1) JP6274161B2 (pt)
CN (1) CN106282181A (pt)
AU (1) AU2016204251B2 (pt)
BR (1) BR102016013818A8 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3527585B2 (ja) 1995-04-19 2004-05-17 明治製菓株式会社 病害抵抗性誘導物質により誘導される遺伝子のプロモーター
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
JP4566993B2 (ja) 2004-03-31 2010-10-20 独立行政法人農業・食品産業技術総合研究機構 病害抵抗性を誘導する農薬のスクリーニング方法およびその方法に使用される植物体
UY29761A1 (es) 2005-08-24 2007-03-30 Du Pont Composiciones que proporcionan tolerancia a múltiples herbicidas y métodos para usarlas
CA2766975A1 (en) 2009-07-01 2011-01-06 Bayer Bioscience N.V. Methods and means for obtaining plants with enhanced glyphosate tolerance
JP5672594B2 (ja) 2010-03-12 2015-02-18 独立行政法人農業生物資源研究所 カビの発現誘導型プロモーター
JP5472089B2 (ja) * 2010-12-28 2014-04-16 トヨタ自動車株式会社 光合成組織における遺伝子発現制御に関わるｄｎａ
WO2012090499A1 (en) 2010-12-28 2012-07-05 Toyota Jidosha Kabushiki Kaisha Mature leaf - specific promoter
JP5828302B2 (ja) 2012-06-21 2015-12-02 トヨタ自動車株式会社 サトウキビ花成制御技術
US20160138032A1 (en) * 2013-03-04 2016-05-19 National Institute Of Agrobiological Sciences Poaceae plant whose flowering time is controllable

Also Published As

Publication number Publication date
AU2016204251B2 (en) 2017-11-02
US10968457B2 (en) 2021-04-06
US20170107528A1 (en) 2017-04-20
AU2016204251A1 (en) 2017-01-19
JP6274161B2 (ja) 2018-02-07
JP2017006086A (ja) 2017-01-12
CN106282181A (zh) 2017-01-04

Similar Documents

Publication Publication Date Title
BR112018011450A2 (pt) métodos e composições para o tratamento de um transtorno associado à serpinc1
CL2017000864A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
BR112018010585A2 (pt) composições de betume compreendendo lignina
CR20200192A (es) Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos
MX2018005829A (es) Composiciones para tratar el cabello.
PH12020550833A1 (en) Rnai constructs for inhibiting pnpla3 expression
BR112014026758A2 (pt) composições de irna de serpinc1 e métodos para uso das mesmas
BR112017006469A2 (pt) composições e métodos para inibição de expressão do gene hao1 (hidroxiácido oxidase 1 (glicolato oxidase))
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
BR112019024813A2 (pt) adenovírus recombinantes portando transgenes
BR112022004699A2 (pt) Vs-6063 em combinação com ch5126766 para o tratamento de câncer
AR105766A1 (es) Polipéptidos que tienen actividad de pululanasa adecuados para usar en licuefacción
BR112016016539A2 (pt) micro-organismos recombinantes enriquecidos com carboidratos
MX2022001017A (es) Composiciones y metodos para inhibir la expresion del gen de sintasa de acido 5'-aminolevulinico 1 (alas1).
ZA201704903B (en) Modified dnase and uses thereof
BR112017027048A2 (pt) processo para extração de pectina e uso da pectina
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
EP3950939A3 (en) Lipase variants and polynucleotides encoding same
BR112018013079A2 (pt) cepas mutantes de trichoderma reesei
BR112017008702A2 (pt) ?mutante de endoxilanase, dna, vetor, célula, método de produção de mutantes de endoxilanase, composição enzimática e método de produção de solução de açúcar?
BR112016015875A2 (pt) Elementos intensificadores de cpmv
BR112017024065A2 (pt) método para tratar insuficiência cardíaca avançada em um indivíduo humano
BR102016013818A8 (pt) promotor induzível por medicamento e método de indução da expressão gênica utilizando o mesmo
CN106687579A8 (zh) 产生二胺的微生物和使用该微生物产生二胺的方法
BR112018000849A2 (pt) ?composições, organismos, sistemas e métodos de cítricos resistentes a patógeno?

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.